Trial Intensifies Concerns About Safety of Vytorin »
Posted By 899webdesign 1 year, 3 months ago in Science & TechnologyIn a clinical trial, the cholesterol -lowering drug Vytorin did not help people with heart-valve disease avoid further heart problems but did appear to increase their risk of cancer , scientists reported Monday.
Read Full Story at nytimes.com »
926 Views Share Story 0 Comments Report
Submitted By:
899webdesign
Thank you for visiting my profile page. I am looking forward that we could share our interests and stories here.
More News
Download Squad
RPGs like Fallout and Oblivion coming to your iPhone?
Windows 7 already bigger than Snow Leopard and Linux combined
You spend more time on MSN Messenger than ANYTHING else
Mozilla Jetpack contest winner harnesses GPU power to process data
Fugly Friday : Aiseikai Hospital has no opthamologist on staff
Science Daily
Hubble Image Showcases Star Birth In M83, The Southern Pinwheel
Raising 'Good' Cholesterol Levels May Benefit Clogged Arteries
Nothing But Net: The Physics Of Basketball Free Throws
'Optical Biopsy' For Breast Cancer Increasingly Accurate, Research Finds
Precuneus Region Of Human And Monkey Brain Is Divided Into Four Distinct Regions
Add a Comment
Sign In With Your Propeller Account
Please keep your comments relevant to this story.
To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br /> tags.